Literature DB >> 22497613

Epileptic encephalitis: the role of the innate and adaptive immune system.

Jan Bauer1, Annamaria Vezzani, Christian G Bien.   

Abstract

Seizures are a prominent clinical feature of encephalitis. Recent data suggest the adaptive as well as innate immune system to be involved directly in the pathomechanism of epileptogenesis. Cytotoxic T-cells and antibody-mediated complement activation are major components of the adaptive immune system, which can induce neurodegeneration, thereby probably contributing to epileptic encephalitis. The innate immune system operates via interleukin-1 and toll-like receptor-associated mechanisms and was shown to play a direct role in epileptogenesis. Here, we review neuropathology hallmarks of various encephalitis conditions such as Rasmussen encephalitis (RE) but also introduce the more recently discovered antibody-associated voltage-gated potassium channel complex (VGKC), N-methyl-D-aspartate receptor (NMDAR) or glutamic acid decarboxylase (GAD) 65 encephalitides. Neuropathological investigations are used to determine specific cellular components and molecular mechanisms used by the immune system to provoke neurodegeneration and to promote epileptogenesis. Based on recent findings, we propose concepts for the stratification of epileptic encephalitis. Knowledge of the role of the innate immunity has already translated into clinical treatment strategies and may help to discover novel drug targets for these epileptic disorders.
© 2012 The Authors; Brain Pathology © 2012 International Society of Neuropathology.

Entities:  

Mesh:

Year:  2012        PMID: 22497613     DOI: 10.1111/j.1750-3639.2012.00580.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  7 in total

Review 1.  Infections, inflammation and epilepsy.

Authors:  Annamaria Vezzani; Robert S Fujinami; H Steve White; Pierre-Marie Preux; Ingmar Blümcke; Josemir W Sander; Wolfgang Löscher
Journal:  Acta Neuropathol       Date:  2015-09-30       Impact factor: 17.088

Review 2.  Targeting inflammation as a therapeutic strategy for drug-resistant epilepsies: an update of new immune-modulating approaches.

Authors:  Giovanna Vitaliti; Piero Pavone; Fahad Mahmood; Giuseppe Nunnari; Raffaele Falsaperla
Journal:  Hum Vaccin Immunother       Date:  2014-03-07       Impact factor: 3.452

Review 3.  Inflammation in neurodegenerative diseases--an update.

Authors:  Sandra Amor; Laura A N Peferoen; Daphne Y S Vogel; Marjolein Breur; Paul van der Valk; David Baker; Johannes M van Noort
Journal:  Immunology       Date:  2014-06       Impact factor: 7.397

Review 4.  Does brain inflammation mediate pathological outcomes in epilepsy?

Authors:  Karen S Wilcox; Annamaria Vezzani
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

5.  Clinical studies and anti-inflammatory mechanisms of treatments.

Authors:  Jacqueline A French; Matthias Koepp; Yvonne Naegelin; Federico Vigevano; Stéphane Auvin; Jong M Rho; Evan Rosenberg; Orrin Devinsky; Peder S Olofsson; Marc A Dichter
Journal:  Epilepsia       Date:  2017-07       Impact factor: 5.864

6.  Cell-Free Mitochondrial DNA in the CSF: A Potential Prognostic Biomarker of Anti-NMDAR Encephalitis.

Authors:  Yu Peng; Dong Zheng; Xiaomei Zhang; Suyue Pan; Teng Ji; Jun Zhang; Hai-Ying Shen; Hong-Hao Wang
Journal:  Front Immunol       Date:  2019-02-06       Impact factor: 7.561

7.  An introduction to the mini-symposium on "The Neuropathology of Focal Human Epilepsy".

Authors:  Ingmar Blümcke
Journal:  Brain Pathol       Date:  2021-07       Impact factor: 6.508

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.